CS228532B2 - Production method of phenylpiperazine derivative - Google Patents

Production method of phenylpiperazine derivative Download PDF

Info

Publication number
CS228532B2
CS228532B2 CS816656A CS665681A CS228532B2 CS 228532 B2 CS228532 B2 CS 228532B2 CS 816656 A CS816656 A CS 816656A CS 665681 A CS665681 A CS 665681A CS 228532 B2 CS228532 B2 CS 228532B2
Authority
CS
Czechoslovakia
Prior art keywords
piperazinyl
trifluoromethylphenyl
group
compounds
formula
Prior art date
Application number
CS816656A
Other languages
Czech (cs)
English (en)
Inventor
Hans H Haeck
Feddo C Hillen
Original Assignee
Duphar Int Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duphar Int Res filed Critical Duphar Int Res
Publication of CS228532B2 publication Critical patent/CS228532B2/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/56Amides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
CS816656A 1980-09-12 1981-09-09 Production method of phenylpiperazine derivative CS228532B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8005133A NL8005133A (nl) 1980-09-12 1980-09-12 Fenylpiperazinederivaten met antiagressieve werking.

Publications (1)

Publication Number Publication Date
CS228532B2 true CS228532B2 (en) 1984-05-14

Family

ID=19835870

Family Applications (1)

Application Number Title Priority Date Filing Date
CS816656A CS228532B2 (en) 1980-09-12 1981-09-09 Production method of phenylpiperazine derivative

Country Status (16)

Country Link
EP (1) EP0048045A1 (de)
JP (1) JPS5781464A (de)
AU (1) AU7502981A (de)
CA (1) CA1155116A (de)
CS (1) CS228532B2 (de)
DD (1) DD202152A5 (de)
DK (1) DK400081A (de)
ES (1) ES8302681A1 (de)
FI (1) FI812808L (de)
GR (1) GR75079B (de)
HU (1) HU184966B (de)
IL (1) IL63784A0 (de)
NL (1) NL8005133A (de)
PL (1) PL232965A1 (de)
YU (1) YU217381A (de)
ZA (1) ZA816256B (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU577802B2 (en) * 1983-10-17 1988-10-06 Duphar International Research B.V. Blood-pressure lowering piperazine derivatives
EP0190472B1 (de) * 1984-12-21 1989-07-12 Duphar International Research B.V Arzneimittel mit antipsychotischer Wirkung
US4778796A (en) * 1985-07-19 1988-10-18 Dainippon Pharmaceutical Co., Ltd. ω-(3-pyridyl)alkenamide derivatives and anti-allergenic pharmaceutical compositions containing same
US5010078A (en) * 1988-05-24 1991-04-23 American Home Products Corporation Aryl- and heteroaryl piperazinyl carboxamides having central nervous system activity
US5254552A (en) * 1988-05-24 1993-10-19 American Home Products Corporation Aryl-and heteroaryl piperazinyl carboxamides having central nervous system activity
GB8909209D0 (en) * 1989-04-22 1989-06-07 Wyeth John & Brother Ltd Piperazine derivatives
US5066680A (en) * 1989-02-14 1991-11-19 Fujisawa Pharmaceutical Co., Ltd. Novel substituted-acetamide compound and a process for the preparation thereof
US5192779A (en) * 1989-02-14 1993-03-09 Fujisawa Pharmaceutical Co., Ltd. Substituted-acetamide compound and a process for the preparation thereof
CA2015033C (en) * 1989-04-22 2000-06-06 American Home Products Corporation Tertiary alkyl functionalized piperazine derivatives
US5340812A (en) * 1989-04-22 1994-08-23 John Wyeth & Brother, Limited Piperazine derivatives
US5382583A (en) * 1989-04-22 1995-01-17 John Wyeth & Brother, Limited Piperazine derivatives
GB2230781B (en) * 1989-04-22 1993-04-28 Wyeth John & Brother Ltd Piperazine derivatives
ES2190428T3 (es) * 1991-06-28 2003-08-01 Smithkline Beecham Corp Antagonistas biciclicos de fibrinogeno.
US5939412A (en) * 1992-06-26 1999-08-17 Smithkline Beecham Corporation Bicyclic fibrinogen antagonists
GB9200293D0 (en) * 1992-01-08 1992-02-26 Wyeth John & Brother Ltd Piperazine derivatives
SE9201138D0 (sv) * 1992-04-09 1992-04-09 Astra Ab Novel phthalimidoalkylpiperazines
JPH0771521B2 (ja) * 1992-07-08 1995-08-02 功司 後藤 靴の製法
SG63579A1 (en) * 1992-12-21 1999-03-30 Smithkline Beecham Corp Bicyclic fibrinogen antagonists
IT1266582B1 (it) * 1993-07-30 1997-01-09 Recordati Chem Pharm Derivati (di)azacicloesanici e diazacicloeptanici
US6403578B1 (en) 1993-12-21 2002-06-11 Smithkline Beecham Corporation Bicyclic fibrinogen antagonists
MA23420A1 (fr) * 1994-01-07 1995-10-01 Smithkline Beecham Corp Antagonistes bicycliques de fibrinogene.
US6458784B1 (en) 1994-06-29 2002-10-01 Smithkline Beecham Corporation Vitronectin receptor antagonists
US5661163A (en) 1995-06-07 1997-08-26 Merck & Co., Inc. Alpha-1a adrenergic receptor antagonists
US5977101A (en) * 1995-06-29 1999-11-02 Smithkline Beecham Corporation Benzimidazoles/Imidazoles Linked to a Fibrinogen Receptor Antagonist Template Having Vitronectin Receptor Antagonist Activity
US5807856A (en) * 1995-11-15 1998-09-15 Merck & Co., Inc. Alpha 1a adrenergic receptor antagonist
CZ315098A3 (cs) 1996-04-05 1999-04-14 Société De Conseils De Recherches Et D'applications Scientifiques (S. C. R. A. S.) Antagonisté alfa1-adrenergických receptorů
DE19624659A1 (de) 1996-06-20 1998-01-08 Klinge Co Chem Pharm Fab Neue Pyridylalken- und Pyridylalkinsäureamide
DE19624704A1 (de) * 1996-06-20 1998-01-08 Klinge Co Chem Pharm Fab Neue Pyridylalkansäureamide
US6451816B1 (en) 1997-06-20 2002-09-17 Klinge Pharma Gmbh Use of pyridyl alkane, pyridyl alkene and/or pyridyl alkine acid amides in the treatment of tumors or for immunosuppression
DE19756236A1 (de) * 1997-12-17 1999-07-01 Klinge Co Chem Pharm Fab Neue piperazinylsubstituierte Pyridylalkan-, alken- und -alkincarbonsäureamide
DE19756261A1 (de) 1997-12-17 1999-07-01 Klinge Co Chem Pharm Fab Neue arylsubstituierte Pyridylalkan-, alken- und alkincarbonsäureamide
DE19756235A1 (de) 1997-12-17 1999-07-01 Klinge Co Chem Pharm Fab Neue piperidinylsubstituierte Pyridylalkan- alken- und -alkincarbonsäureamide
US6903118B1 (en) 1997-12-17 2005-06-07 Klinge Pharma Gmbh Piperazinyl-substituted pyridylalkane, alkene and alkine carboxamides
DE19756212A1 (de) 1997-12-17 1999-07-01 Klinge Co Chem Pharm Fab Neue, mit einem cyclischen Imid substituierte Pyridylalkan-, alken- und -alkincarbonsäureamide
EP1031564A1 (de) 1999-02-26 2000-08-30 Klinge Pharma GmbH Hemmer der Nicotinamidmonononukleotide-Bildung und deren Verwendung zur Krebstherapie
WO2003086393A1 (en) * 2002-04-12 2003-10-23 Sepracor, Inc. 3-aza- and 1,4-diaza-bicyclo[4.3.0]nonanes, and methods of use thereof
CA2489396A1 (en) * 2002-07-04 2004-01-15 Schwarz Pharma Ag Utilization of heteroarene carboxamide as dopamine-d3 ligands for the treatment of cns diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1088058B (de) * 1956-08-21 1960-09-01 Davis & Company Verfahren zur Herstellung von sympatholytisch wirkenden N-o-Halogenphenyl-N'-acylamino-alkylpiperazinen und deren Saeuresalzen
GB1166364A (en) * 1966-11-25 1969-10-08 American Cyanamid Co N-(Tert-Aminoalkyl) Amide Derivatives and Process for Preparing the Same
BE788280A (fr) * 1971-09-04 1973-02-28 Pfizer Nouvelles 1-(3-trifluoro-methyl-phenyl)-4-((amido cyclique)- alkyl) piperazines et composition pharmaceutique les contenant
AU532411B2 (en) * 1979-03-01 1983-09-29 Duphar International Research B.V. Phenyl piperazine derivatives

Also Published As

Publication number Publication date
GR75079B (de) 1984-07-13
HU184966B (en) 1984-11-28
JPS5781464A (en) 1982-05-21
AU7502981A (en) 1982-03-18
ES505373A0 (es) 1982-12-01
ES8302681A1 (es) 1982-12-01
CA1155116A (en) 1983-10-11
YU217381A (en) 1983-09-30
DD202152A5 (de) 1983-08-31
FI812808L (fi) 1982-03-13
IL63784A0 (en) 1981-12-31
ZA816256B (en) 1982-08-25
NL8005133A (nl) 1982-04-01
DK400081A (da) 1982-03-13
PL232965A1 (de) 1982-10-25
EP0048045A1 (de) 1982-03-24

Similar Documents

Publication Publication Date Title
CS228532B2 (en) Production method of phenylpiperazine derivative
JP4145955B2 (ja) ピロロ〔2,3−d〕ピリミジン及びその使用
EP0343961B1 (de) Aryl- und Heteroaryl-piperazinylcarboxamide mit Wirkung auf das zentrale Nervensystem
FI88504B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 4-benzyl-1-(2h)-ftalazinonderivat
EA006430B1 (ru) Производные n-(арилсульфонил)бета-аминокислот, содержащие замещенную аминометильную группу, способ их получения и содержащие их фармацевтические композиции
EP0773937A1 (de) Von arylpiperazinen abgeleitete piperzide und ihre verwendung als medikament
CA2378499A1 (en) Cyclic amine ccr3 antagonists
HRP930508A2 (en) Difenilpropilamina process for the preparation of the novel enylpropylamine derivatives
JP2005525332A (ja) 5−ht6受容体アフィニティーを有するスルホニル化合物
IE51179B1 (en) Pyridoxine derivatives,process for preparing them and use in therapeutics
JP2006519812A (ja) フェニルスルホン誘導体およびcns障害の治療におけるその使用
EP0325406B1 (de) Diamin-Verbindungen
FI80448C (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara piperazinkarboxamidderivat.
SK277973B6 (en) 1,2 - etanediole derivatives and their salts, and method of their production
US5214047A (en) Tetracyclic quinazoline derivatives, effective as antiarrythmic agents
WO1998047887A1 (fr) Nouveaux derives d'epoxysuccinamide et sels associes
CS216525B2 (en) Method of making the phenylpiperazine derivatives
CS274446B2 (en) Method of 1-acyl-3-/4-/2-pyrimidinyl/-1-piperazinyl/propanes production
CS274494B2 (en) Method of substituted styrene derivatives preparation
JPH0135822B2 (de)
KR100305630B1 (ko) N-아미노알킬-2-안트라퀴논카르복스아미드:신규한도파민수용체서브타입특이적리간드
IT9021305A1 (it) Derivati aminopropanolici, procedimenti per la loro preparazione e composizioni farmaceutiche che li contengono
EP0388081B1 (de) Verbindung zur Behandlung von Störungen des Neurotransmittersystems im Gehirn
HRP980216A2 (en) Therapeutic 1,2,3,4-tetrahydroisoquinolines
US5439940A (en) Benz[e]indene derivatives